Development of Protein-Observed Fluorine Nuclear Magnetic Resonance Spectroscopy as a Ligand Discovery Technique
2017-04
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Development of Protein-Observed Fluorine Nuclear Magnetic Resonance Spectroscopy as a Ligand Discovery Technique
Authors
Published Date
2017-04
Publisher
Type
Thesis or Dissertation
Abstract
Fragment-based drug design (FBDD) has been rapidly gaining traction in the drug discovery process. A central tenant of fragment-based molecular screening is to use less sophisticated small molecules to sample chemical space more efficiently. With Vemurafenib and Venetoclax as FDA approved therapeutics from FBDD and several others in Phase III clinical trials, FBDD is becoming a validated technique for drug discovery. However, because of their small size these fragments are likely to bind to their target with a low affinity, necessitating more sensitive methods to detect protein-ligand interactions during a screen. Nuclear magnetic resonance spectroscopy has emerged as one of several powerful biophysical techniques for conducting fragment screens. In this thesis, a 19F protein-observed NMR method for detecting bromodomain−ligand interactions using fluorine-labeled aromatic amino acids due to the conservation of aromatic residues in the bromodomain binding site is described. Therein, we test the sensitivity, accuracy, and speed of this method with small molecule ligands. Experiment times on the order of a few minutes and the simplicity of the NMR spectra obtained make this approach well-suited to the investigation of small- to medium-sized proteins, as well as the screening of multiple proteins in the same experiment. Simplified 19F NMR spectra allowed for simultaneous testing of multiple bromodomains to assess selectivity and identification of a new BPTF ligand. Fluorine labeling only modestly affected the Brd4 structure and function assessed by isothermal titration calorimetry, circular dichroism, and X-ray crystallography. To benchmark its potential as a ligand discovery tool, we compare the protein-observed 19F NMR screening method with the well-characterized ligand-observed 1H CPMG NMR screen. We selected the first bromodomain of Brd4 as a model system because of the high ligandability of Brd4 and the need for small molecule inhibitors of related epigenetic regulatory proteins. We conclude that for the protein class understudy here, protein-observed 19F NMR and 1H CPMG have similar sensitivity, with both being effective tools for ligand discovery. The speed, ease of interpretation, and low concentration of protein needed for binding experiments affords a new method to discover and characterize both native and new ligands.
Description
University of Minnesota Ph.D. dissertation. April 2017. Major: Chemistry. Advisor: William Pomerantz. 1 computer file (PDF); xvi, 264 pages.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Urick, Andrew. (2017). Development of Protein-Observed Fluorine Nuclear Magnetic Resonance Spectroscopy as a Ligand Discovery Technique. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/188870.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.